Pharmaceutical manufacturers must address the question of how exactly does value get created and destroyed inside these organizations and how will AI fundamentally shift that equation?
Pavitra Velan
Advertisement
Articles by Pavitra Velan
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Nimbus Therapeutics and Eli Lilly Enter $1.3 Billion License Agreement and Research Collaboration for Oral Obesity Treatments
2
Amgen Acquires Dark Blue Therapeutics in $840 Million Transaction
3
The Real Value Equation: How Humans and AI Create and Destroy Value in Pharma
4
Novo Nordisk’s Wegovy Pill Becomes First Oral GLP-1 Available in U.S.
5